Skip to main content
. 2022 Jan 23;11(3):568. doi: 10.3390/jcm11030568

Table 2.

Bivariate correlations of the aMED score.

SCZ HCs
BMI, kg/m2 r = −0.320, p = 0.003 r = 0.034, p = 0.799
RBANS—global cognition r = −0.058, p = 0.601 r = −0.111, p = 0.400
RBANS—immediate memory r = −0.077, p = 0.485 r = −0.066, p = 0.618
RBANS—visuospatial/constructional r = −0.005, p = 0.967 r = −0.218, p = 0.094
RBANS—language r = 0.028, p = 0.802 r = 0.218, p = 0.094
RBANS—attention r = −0.055, p = 0.622 r = −0.107, p = 0.416
RBANS—delayed memory r = −0.109, p = 0.324 r = −0.111, p = 0.397
CPZeq r = −0.044, p = 0.691 -
CDSS r = −0.085, p = 0.443 -
PANSS—negative symptoms r = −0.249, p = 0.022 -
SNS—total score r = −0.303, p = 0.005 -
SNS—social withdrawal r = −0.129, p = 0.243 -
SNS—diminished emotional range r = −0.111, p = 0.316 -
SNS—alogia r = −0.289, p = 0.008 -
SNS—avolition r = −0.363, p < 0.001 -
SNS—anhedonia r = −0.279, p = 0.010 -
SOFAS r = 0.183, p = 0.095 -

Significant correlations (p < 0.05) were marked with bold characters. Abbreviations: BMI—body mass index; CDSS—the Calgary Depression Scale for Schizophrenia; CPZeq—chlorpromazine equivalent dosage; SOFAS—the Social and Occupational Functioning Assessment Scale; HCs—healthy controls; PANSS—the Positive and Negative Syndrome Scale; RBANS—the Repeatable Battery for the Assessment of Neuropsychological Status; SCZ—individuals with schizophrenia; SNS—the Self-Evaluation of Negative Symptoms.